ANASTASIYA APANASYUK: Open Payments
NPI 1033518782 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 14 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $281 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Syndax Pharmaceuticals, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Tactile Systems Technology Inc | 1 | $28 |
| GENZYME CORPORATION | 1 | $27 |
| SOBI, INC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| TAIHO ONCOLOGY, INC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: KISQALI, REVUFORJ, Cresemba, Enhertu, Flexitouch Plus, SARCLISA, Vonjo, JEMPERLI.
Industry payments across NY — which companies pay providers there.
